×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ILMN – illumina, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ILMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
09:35 am
ilmn
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering [Yahoo! Finance]
Low
Report
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering [Yahoo! Finance]
3/5
09:15 am
ilmn
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
Low
Report
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
3/5
08:48 am
ilmn
Illumina (ILMN) Gaining from Stronger Than Expected Results [Yahoo! Finance]
Low
Report
Illumina (ILMN) Gaining from Stronger Than Expected Results [Yahoo! Finance]
3/5
05:02 am
ilmn
Genomics Services Market Projected to Surpass USD 25.18 Billion by 2035; Increasing Genetic Disorders' Prevalence is Driving Market Growth Globally – SNS Insider [Yahoo! Finance]
Low
Report
Genomics Services Market Projected to Surpass USD 25.18 Billion by 2035; Increasing Genetic Disorders' Prevalence is Driving Market Growth Globally – SNS Insider [Yahoo! Finance]
2/27
09:23 am
ilmn
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida [Yahoo! Finance]
Medium
Report
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida [Yahoo! Finance]
2/27
09:15 am
ilmn
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
Medium
Report
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
2/26
07:13 pm
ilmn
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics [Yahoo! Finance]
Medium
Report
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics [Yahoo! Finance]
2/26
07:00 pm
ilmn
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
Medium
Report
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/24
04:11 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 20 Filed by: Davies Scott M
Low
Report
Form 4 ILLUMINA, INC. For: Feb 20 Filed by: Davies Scott M
2/20
04:28 pm
ilmn
Form 144 ILLUMINA, INC. Filed by: Davies Scott M
Low
Report
Form 144 ILLUMINA, INC. Filed by: Davies Scott M
2/18
04:57 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Barnard Steven
Low
Report
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Barnard Steven
2/18
04:55 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Ericksen Scott D
Low
Report
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Ericksen Scott D
2/18
04:54 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Pegels Kevin Carl
Low
Report
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Pegels Kevin Carl
2/18
04:53 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Davies Scott M
Low
Report
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Davies Scott M
2/18
04:52 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Thaysen Jacob
Low
Report
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Thaysen Jacob
2/18
04:50 pm
ilmn
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Wedel Christensen Jakob
Low
Report
Form 4 ILLUMINA, INC. For: Feb 15 Filed by: Wedel Christensen Jakob
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Illumina, Inc. (ILMN): Are Hedge Funds Right About This Stock? [Yahoo! Finance News]
9.2%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
3/17 IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions 5.0%
4/3 Form 4 ILLUMINA, INC. For: Apr 01 Filed by: Dadswell Charles 4.5%
10/26 Illumina, Inc. (NASDAQ: ILMN) had its price target raised by analysts at Canaccord Genuity from $300.00 to $310.00. They now have a "hold" rating on the stock. 4.5%
4/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19 4.2%
3/26 Illumina, Inc. (NASDAQ: ILMN) had its price target lowered by analysts at Barclays PLC from $390.00 to $350.00. They now have an "overweight" rating on the stock. 3.7%
6/28 BRIEF-Illumina Files Patent Infringement Suits Related To Bgi In Switzerland, Turkey And The Us [Reuters] 3.6%
6/3 Form 8-K ILLUMINA INC For: May 29 3.3%
3/9 Form 4 ILLUMINA, INC. For: Mar 05 Filed by: Hoyt Aimee L 3.2%
10/8 Illumina to Announce Third Quarter 2019 Financial Results on Thursday, October 24, 2019 3.0%
TOP News Decliners
7/11
Illumina Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019
-15.3%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
10/24 Form 8-K ILLUMINA, INC. For: Oct 24 -12.5%
4/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020 -7.3%
1/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 -6.6%
5/10 Form 4 ILLUMINA INC For: May 08 Filed by: FLATLEY JAY T -4.7%
10/7 Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -4.4%
2/25 Did You Miss Illumina's (NASDAQ:ILMN) 68% Share Price Gain? [Yahoo! Finance News] -3.7%
4/20 Form 4 ILLUMINA, INC. For: Apr 16 Filed by: Van Oene Mark -3.6%
8/13 Form 4 ILLUMINA INC For: Aug 09 Filed by: OSTADAN OMEAD -3.6%
2/6 Form 4 ILLUMINA, INC. For: Feb 05 Filed by: Van Oene Mark -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: